Medical News

RSS

Vaccination does not alter post-COVID smell and taste loss

Researchers examining whether COVID-19 vaccination affects persistent smell or taste problems after contracting the virus have found that, in most cases, it does not.

20 Oct 2026

Restless legs syndrome triples the risk of perinatal depression in pregnant women

New research found a higher risk of perinatal depression in pregnant women with restless legs syndrome.

20 Oct 2026

Deep learning model automates right ventricular assessment from echocardiograms

Mostafa Al-Alusi, MD, MS, and Patrick T. Ellinor, MD, PhD, of the Mass General Brigham Heart and Vascular Institute, are the lead and senior authors of a paper published in Nature Cardiovascular Research, "Deep Learning-Enabled Assessment of Right Ventricular Size and Function is Associated with Cardiovascular Outcomes."

20 Oct 2026

Simple medical card game reduces preoperative anxiety in children

Preoperative anxiety affects about 60% of children and is linked with poorer cooperation at anesthesia induction, greater postoperative pain, and maladaptive behavioral changes.

20 Oct 2026

Naturally occurring blood molecule linked to lower Alzheimer's risk

Researchers developed a drug for Alzheimer's disease, and then discovered that the molecule already exists in human blood, and is found in lower levels in cognitively impaired people.

20 Oct 2026

Study links abnormal immature astroglia to lower fluid intelligence in older epilepsy patients

A new USC-led study links abnormal immature astroglia, star-shaped cells that support brain function, to lower fluid intelligence, or the ability to solve new problems, in older adults with epilepsy.

20 Oct 2026

Novel "Raman genome" concept enables rapid tracking of viruses

A research team led by Distinguished Professor Giuseppe Pezzotti at the Biomedical Engineering Center, Kansai Medical University, has demonstrated that differences in the molecular structures of viral RNA can be captured as "Raman barcodes," enabling the identification of 20 SARS-CoV-2 variants and subvariants.

20 Oct 2026

Scientists find a way to boost the body's natural viral defenses

Washington State University researchers have discovered how to "crank up" a natural defense system in the body to combat viral infection, potentially opening a new door for treating virus infections, cancer, neurological disorders and other diseases.

20 Oct 2026

Asian study shows ADHD disability burden peaks in early adolescence

Attention-deficit/hyperactivity disorder (ADHD) is the most common neurodevelopmental disorder and imposes a lifelong burden extending beyond core symptoms to academic achievement, quality of life, and long-term disability.

20 Oct 2026

Scientists discover immune pathway behind radiation-induced lung damage

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the country, have uncovered an immune pathway that may contribute to radiation-related lung damage and have identified a potential strategy to block it.

20 Oct 2026

Machine learning can identify older heart failure patients at risk of losing independence

For older adults with heart failure (HF), leaving the hospital alive does not always mean returning to an independent life. Loss of independence can reduce quality of life, increase caregiver burden, and raise care needs.

20 Oct 2026

Targeted ultrasound waves safely reduce delusions in people with schizophrenia

Targeting a deep brain region with sound waves may safely reduce delusions in people with schizophrenia and schizoaffective disorder, initial study results show.

20 Oct 2026

Perceptions of science and scientists shape partisan views on common vaccines

How Americans view science and scientists is strongly associated with whether they think vaccines are safe and effective - and helps explain partisan differences in perceptions of some vaccines, according to a new study led by a team from the Annenberg Public Policy Center (APPC) of the University of Pennsylvania.

20 Oct 2026

Caregivers with heart disease face high psychological distress risks

Family caregivers often put their own health second. For those already living with cardiovascular conditions, caregiving can add to their physical and emotional strain.

20 Oct 2026

Anxiety and depression linked to higher levels of pregnancy "brain fog"

Symptoms of anxiety and depression are associated with higher levels of "pregnancy brain," which is also known as "baby brain," "brain fog" or "momnesia," according to a new study by Penn State researchers.

20 Oct 2026

Preschool social-emotional lessons improve long-term adult well-being

Almost two decades later, preschool students who received supplemental instruction to build their social, emotional and language skills reported a higher quality of life than peers who did not receive the same skill instruction, according to an interdisciplinary team of Penn State researchers.

20 Oct 2026

Hunger may drive the propensity to develop alcohol addiction

Researchers at Brown University have discovered a molecular link between hunger and the formation of "reward" memories that play a role in alcohol addiction.

20 Oct 2026

Routine liver cancer screening extends lives for patients with alcohol-associated cirrhosis

A new study led by investigators from Mass General Brigham found routine liver cancer screening to be cost-effective and life-extending for individuals with alcohol-associated cirrhosis, even when their annual risk of developing liver cancer is less than half the risk level guiding current screening recommendations.

20 Oct 2026

New program helps high-risk children improve sun protection behaviors

Children of parents who have melanoma, a serious type of skin cancer that starts in the cells that make pigment, have twice the lifetime risk of developing the disease themselves.

20 Oct 2026

S2N.Bio commences technology transfer of Alzheimer’s cell therapy to Cell Therapies’ Melbourne GMP facility

Cell Therapies Pty Ltd and S2N.Bio (“S2N”) have commenced technology transfer of S2N’s cell therapy candidate for Alzheimer’s disease. The transfer will enable GMP manufacture of clinical trial material for S2N’s first-in-human study in Australia.

20 Oct 2026